Skip to content

Ultrasound-guided modified thoracoabdominal nerves block through perichondrial approach (M-TAPA) in postoperative analgesia in robot-assisted laparoscopic partial nephrectomy: a randomized, double-blind controlled trial

Ultrasound-guided modified thoracoabdominal nerves block through perichondrial approach (M-TAPA) in postoperative analgesia in robot-assisted laparoscopic partial nephrectomy: a randomized, double-blind controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500097757
Enrollment
Unknown
Registered
2025-02-25
Start date
2025-02-28
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative analgesia in robot-assisted laparoscopic partial nephrectomy

Interventions

modified thoracoabdominal nerves block through perichondral approach, group M:Ultrasound-guided modified-thoracoabdominal nerve block through a perichondrial approach
control group (group C):local anesthesia on the incision surface

Sponsors

Beijing Friendship Hospital ,Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients undergoing robot-assisted laparoscopic partial nephrectomy at Beijing Friendship Hospital affiliated to Capital Medical University had no contraindications to surgical anesthesia. ASA class I-III, age 18-80 years. Patients and their families signed the informed consent form, were able to understand and cooperate with the VAS score, and had good compliance.

Exclusion criteria

Exclusion criteria: Patient refuses to sign informed consent. Coagulopathy. Neuropathy. Allergy to local anesthetic drugs. Infection at the puncture site. Severe cardiopulmonary liver and kidney function diseases. Mental illness. History of substance abuse. History of acute or chronic pain.

Design outcomes

Primary

MeasureTime frame
equivalent intravenous morphine converted from opioid consumption;

Secondary

MeasureTime frame
VAS scores at rest and during movement at postoperative 2, 6, 12, 24 and 48?hours;number of effective compressions of the analgesic pump; consumption of rescue analgesia ;incidences of postoperative agitation;incidences of postoperative nausea and vomiting ;incidences of postoperative respiratory depression within 48h postoperative;time of postoperative gastrointestinal function recovery;time of first feeding;time to first ambulation;length of hospital stay;

Countries

China

Contacts

Public ContactTong JiaQi

Beijing Friendship Hospital ,Capital Medical University

569220372@qq.com+86 185 1869 7198

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026